Insider Selling: Organigram Holdings Inc. (TSE:OGI) Senior Officer Sells C$30,275.28 in Stock

Organigram Holdings Inc. (TSE:OGI) Senior Officer Paolo De Luca sold 12,014 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28.

Paolo De Luca also recently made the following trade(s):

• On Wednesday, September 11th, Paolo De Luca sold 13,835 shares of Organigram stock. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90.
• On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The stock was sold at an average price of C$2.76, for a total transaction of C$28,334.16.

Organigram Price Performance

OGI opened at C$2.36 on Friday. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The business’s fifty day simple moving average is C$2.46 and its 200-day simple moving average is C$2.40. The company has a market capitalization of C$256.23 million, a price-to-earnings ratio of -0.94, a PEG ratio of 0.42 and a beta of 1.13. Organigram Holdings Inc. has a 12-month low of C$1.41 and a 12-month high of C$3.95.

Organigram (TSE:OGI) last posted its earnings results on Tuesday, August 13th. The company reported C$0.03 EPS for the quarter, beating analysts’ consensus estimates of C($0.07) by C$0.10. Organigram had a negative net margin of 153.80% and a negative return on equity of 54.53%. The business had revenue of C$41.06 million for the quarter, compared to the consensus estimate of C$39.20 million. On average, equities research analysts anticipate that Organigram Holdings Inc. will post 0.1632373 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group upped their target price on shares of Organigram from C$3.25 to C$3.60 and gave the stock a “speculative buy” rating in a research note on Wednesday, August 14th.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.